If we’re serious about curbing opioid misprescribing, misuse and abuse, we need mandatory physician education. Now.
Congress's stopgap measures are inconvenient for most agencies, but when it comes to Indian Health Service funding, these delays are measured in lives.
The issue of naming for biosimilars is not about competition, it is a matter of sound science.
The United States should be teaching the United Nations about disability rights.
I have seen many instances early in my career when the FDA has worked well, so I know it is possible.
It’s time for Congress to ensure that every American community has adequate access to veterinary care.
This month, the U.S. Food and Drug Administration (FDA) approved the third new prescription drug for obesity since 2012.
Patient voices must develop a new play book if they are serious about achieving results.
It is critically important to advance public policy that will help halt the upward trajectory of the diabetes epidemic.
I am one of thousands of people with T1D who are being put at risk because Medicare doesn’t cover the cost of CGM devices.